Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.
Leggi
Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.
Leggi
21/03/2024
Leggi
21/03/2024
Leggi
Rivera FB, Lumbang GNO, Gaid DRM, et al.
Diabetes Obes Metab. Pub. online 20 Mar 2024.
Leggi
21/03/2024
Leggi
Zhou BG, Xia JL, Jiang X, et al.
BMC Endocr Disord. 2024;24(1):40.
Leggi
Garg SK, Akturk HK, Kaur G, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
Bell DSH, Jerkins T
Diabetes Obes Metab. Pub. online 22 Mar 2024.
Leggi
Martine-Edith G, Zaremba N, Divilly P, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
Lee CG, Ciarleglio A, Edelstein SL, et al.
Diabetes Care. 2024;dc232009.
Leggi